indolent systemic mastocytosis
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
systemic mastocytosis subtype |
| gptkbp:affects |
gptkb:skin
gastrointestinal tract bone marrow immune system |
| gptkbp:causedBy |
KIT gene mutation
|
| gptkbp:hasDiagnosticMethod |
bone marrow biopsy
skin biopsy serum tryptase level |
| https://www.w3.org/2000/01/rdf-schema#label |
indolent systemic mastocytosis
|
| gptkbp:ICD-10_code |
D47.02
|
| gptkbp:prevalence |
rare
|
| gptkbp:prognosis |
generally favorable
|
| gptkbp:subclassOf |
gptkb:mast_cell_disease
gptkb:systemic_mastocytosis |
| gptkbp:symptom |
diarrhea
abdominal pain anaphylaxis bone pain flushing skin lesions |
| gptkbp:treatment |
corticosteroids
epinephrine antihistamines mast cell stabilizers |
| gptkbp:bfsParent |
gptkb:systemic_mastocytosis
|
| gptkbp:bfsLayer |
6
|